G01N 2333/9128
Rna-directed dna polymerases
Official title: RNA-directed DNA polymerases, e.g. RT (2.7.7.49)
G01N2333/9128 (Rna-directed dna polymerases) appears on 22 US grants and 42 published applications in this corpus.
Search patents in G01N- Granted patents
- 22
- Published applications
- 42
- Assignees
- 34
- Inventors
- 107
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 2 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 5 |
| 2016 | 0 | 3 |
| 2017 | 2 | 6 |
| 2018 | 0 | 0 |
| 2019 | 7 | 1 |
| 2020 | 1 | 4 |
| 2021 | 0 | 3 |
| 2022 | 2 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 5 |
| 2025 | 1 | 2 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Screening method for telomerase reverse transcriptase (TERT) phosphorylation inhibitors17 Mar 2026US 12,577,555 B2
- Methods of treating myelodysplastic syndrome21 Jan 2025US 12,201,645 B2Geron Corporation
- Method of detecting cancer19 Jul 2022US 11,391,738 B2Sienna Cancer Diagnostics Inc.
- Single domain antibodies directed against arachidonate 12-lipoxygenase4 Jan 2022US 11,214,626 B2Singh Biotechnology, LLC
- Universal cancer peptides derived from telomerase30 Jun 2020US 10,695,409 B2Centre Hospitalier Regional Universitaire De Besancon
- Semi-quantitative electrochemical biosensor system and method for pathogenic organism nucleic acid detection13 Aug 2026US 2026/0233218 A1eDNA Biotech, Inc.
- Distinctive identification and use of a liquid biopsy cancer biomarker for cancer detection, management and treatment6 Aug 2026US 2026/0227409 A1Rarecells SAS
- Development of a rapid enzymatic assay for antiretroviral drug monitoring using crispr reporters21 May 2026US 2026/0139294 A1University of Washington
- Methods of Treating Myelodysplastic Syndrome29 May 2025US 2025/0170160 A1Geron Corporation
- Programmable nuclease-based assay improvements10 Apr 2025US 2025/0115950 A1Mammoth Biosciences, Inc.
Most cited
By later US patents
- Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase152US 5,503,978 AUniversity Research Corporation · 1996
- High affinity ssDNA ligands of HIV-1 reverse transcriptase113US 5,786,462 ANeXstar Pharmaceuticals, Inc. · 1998
- Method for cancer detection, diagnosis and prognosis15US 8,551,425 B2California Institute of Technology · 2013
- Methods for cancer detection, diagnosis and prognosis15US 9,182,387 B2California Institute of Technology · 2015
- Phosphonucleosides useful in the treatment of viral disorders13US 9,822,137 B2Katholieke Universiteit Leuven · 2017